Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Rowland J. Bright-Thomas

Consultant respiratory physician at The Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester

Recent stories

  • Possible compromises for the dosing of IV tobramycin in cystic fibrosisSubscription

    PJ, January 2013

    Intraveous tobramycin is one of the mainstay antibiotics in the treatment of respiratory exacerbation in cystic fibrosis. Panel 1 gives some background information on the disease, Panel 2 describes the importance of Pseudomonas aeruginosa infection in CF patients, and Panel 3 explains the uses of this medicine. Panel 1: Wh

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.